1. Chu, Bo, Kon, Ning, Chen, Delin, Tavana, Omid, Gu, Wei. 2019. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. In Nature cell biology, 21, 579-591. doi:10.1038/s41556-019-0305-6. https://pubmed.ncbi.nlm.nih.gov/30962574/
2. Zhang, Xiao-Jing, She, Zhi-Gang, Wang, Junyong, Wang, Yibin, Li, Hongliang. 2021. Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis. In Science translational medicine, 13, eabg8117. doi:10.1126/scitranslmed.abg8117. https://pubmed.ncbi.nlm.nih.gov/34910546/
3. Al-E-Ahmad, Atiyeh, Parsian, Hadi, Fathi, Mojtaba, Nooreddini, Haji Ghorban, Mosapour, Abbas. . ALOX12 gene polymorphisms and serum selenium status in elderly osteoporotic patients. In Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 27, 1717-1722. doi:10.17219/acem/75689. https://pubmed.ncbi.nlm.nih.gov/30277667/
4. Harsløf, T, Husted, L B, Nyegaard, M, Rejnmark, L, Langdahl, B L. 2010. Polymorphisms in the ALOX12 gene and osteoporosis. In Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 22, 2249-59. doi:10.1007/s00198-010-1472-2. https://pubmed.ncbi.nlm.nih.gov/21104233/
5. Wang, Meixi, Wang, Jingjing, Wang, Jinni, Wu, Yonggui, Qi, Xiangming. 2024. Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease. In Renal failure, 46, 2313182. doi:10.1080/0886022X.2024.2313182. https://pubmed.ncbi.nlm.nih.gov/38345057/
智鼠故事 
